InfuSystem Holdings (INFU) Cash & Equivalents Growth (3y) (2013 - 2026)
InfuSystem Holdings (INFU) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 32.23% |
| 10 | InfuSystem Holdings | 242.86 Mn | 241.90 Mn | 21.41 Mn | 93.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.04% |
| Mar 31, 2026 | 101.87% |
| Dec 31, 2025 | 168.28% |
| Sep 30, 2025 | 38.05% |
| Jun 30, 2025 | 32.29% |
| Mar 31, 2025 | 54.93% |
| Dec 31, 2024 | 41.50% |
| Sep 30, 2024 | 32.06% |
| Jun 30, 2024 | -3.80% |
| Mar 31, 2024 | -33.23% |
| Dec 31, 2023 | -71.18% |
| Sep 30, 2023 | -56.37% |
| Jun 30, 2023 | -34.73% |
| Mar 31, 2023 | -5.67% |
| Dec 31, 2022 | -60.35% |
| Sep 30, 2022 | -51.37% |
| Jun 30, 2022 | -43.25% |
| Mar 31, 2022 | -40.26% |
| Dec 31, 2021 | -64.95% |
| Sep 30, 2021 | -65.10% |